Company Description

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expert-based contract research, consulting, medical communications, and technology solutions to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the devel... More >>

Q4 2016 Quarterly ResultsMore Info >>
Earnings Press Release
 Form 8-K
Q4 Financial Results and Trended Information

Recent NewsMore Info >>
8/3/16
PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results
7/11/16
PAREXEL International Announces Date of Fourth Quarter and Fiscal Year 2016 Earnings Release and Conference Call
6/30/16
PAREXEL International Outlines Growth Strategy And Updates Financial Guidance At Investor Day

EventsMore Info >>
PAREXEL International Investor Day 2016
Thursday, June 30, 2016 9:00 a.m. ET
Supporting Materials
Download Event Supporting Material PAREXEL’s 2016 Investor Day Presentation